NextCure, Inc. — Director's Dealing 2020

Sep 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2020-09-10

Reporting Person: Houston John G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-10	Stock Option (Right to Buy)	$9.14	A	28500	Acquired	2030-09-09	Common Stock (28500)	Direct
2020-09-10	Stock Option (Right to Buy)	$9.14	A	10687	Acquired	2030-09-09	Common Stock (10687)	Direct

Footnotes

F1: The option vests in three equal annual installments beginning on September 10, 2021.

F2: The option vests on the earlier of June 11, 2021 and immediately prior to the 2021 Annual Meeting of Stockholders.